• Revolution Medicines average return on tangible equity for 2023 was -41.15, a 7.74% decline from 2022.
• Revolution Medicines average return on tangible equity for 2022 was -44.6, a 51.44% decline from 2021.
• Revolution Medicines average return on tangible equity for 2021 was -29.45, a 35.33% increase from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.